Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Mutational signature and prognosis in adenocarcinoma of the bladder.

The Journal of pathology - 1 Mar 2024

Yang Guoliang, Shahatiaili Akezhouli, Bai Shihao, Wang Liyang, Jin Di, Cao Ming, Su Peipei, Liu Qiang, Tao Kun, Long Qi, Shi Yi, Xiao Jing, Tian Futong, Zhang Lianhua, Chen Haige, Su Xianbin

Abstract excerpt

Adenocarcinoma of the bladder is a rare urinary bladder carcinoma with limited therapy options due to lack of molecular characterization. Here, we aimed to reveal the mutational and transcriptomic landscapes of adenocarcinoma of the bladder and assess any relationship with prognosis. Between February 2015 and June 2021, a total of 23 patients with adenocarcinoma of the bladder were enrolled. These included 16...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Carcinogens

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Prognosis

Share to Urinary Bladder

Source

Identifiers

PMID: 38180342
DOI: 10.1002/path.6239

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Mutational signature and prognosis in adenocarcinoma of the bladder.PMID 38180342Read ↗

Beyond driver mutations: exploring the landscape of mutational signatures in adenocarcinomas of the bladder†.Semantic proximity Read ↗

Bladder Cancer: Update on Risk Factors, Molecular and Ultrastructural Patterns.Semantic proximity Read ↗

Cellular origins and etiological factors for squamous cell carcinoma and related cancer types of the bladder.Semantic proximity Read ↗

Molecular Profiling of Bladder Adenocarcinoma Using a National Genomics RepositorySemantic proximity Read ↗

Genetic characteristics and targeted treatments of primary bladder and urachal adenocarcinomas: a systematic review with pooled descriptive genomic analyses.Semantic proximity Read ↗

[Molecular classification of bladder cancer in 2021].Semantic proximity Read ↗

Identification of a tobacco-smoking induced mutation signature with biological and clinical significance in bladder cancerSemantic proximity Read ↗

Comprehensive genomic profiling of neuroendocrine bladder cancer pinpoints molecular origin and potential therapeutics.Semantic proximity Read ↗

Advances in Therapy for Urothelial and Non-Urothelial Subtype Histologies of Advanced Bladder Cancer: From Etiology to Current DevelopmentSemantic proximity Read ↗

Comparison of Genomic Characterization in Upper Tract Urothelial Carcinoma and Urothelial Carcinoma of the BladderSemantic proximity Read ↗

Molecular profile of micropapillary urothelial carcinoma of the urinary bladder: An analysis of 99 cases by next-generation sequencing.Semantic proximity Read ↗

Genomic subtypes of non-muscle-invasive bladder cancer: guiding immunotherapy decision-making for patients exposed to aristolochic acidSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.